News|Articles|June 2, 2001
- Pharmaceutical Technology-06-02-2001
- Volume 25
- Issue 6
Viral Clearance Strategies for Biopharmaceutical Safety
Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.
Advertisement
Articles in this issue
over 24 years ago
Outsourcing Outlookover 24 years ago
Managing Risks and Resourcesover 24 years ago
Blister News: COC Resin, Foil, and Lidding Innovationsover 24 years ago
Managing the Risks in Outsourcingover 24 years ago
Systemic Drug Delivery via the Buccal Mucosal RouteNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
